Abstract
Cell-penetrating peptides (CPPs) are small peptides which help intracellular delivery of functional macromolecules, including DNAs, RNAs, and proteins, across the cell membrane and into the cytosol, and even into the nucleus in some cases. Delivery of macromolecules can facilitate transfection, aid in gene therapy and transgenesis, and alter gene expression. L5a (RRWQW), originally derived from bovine lactoferricin, is one kind of CPPs which can promote cellular uptake of plasmid DNA and enters cells via direct membrane translocation. The peptide complexes noncovalently with DNA over a short incubation period. DNA plasmid and L5a complex stability is confirmed by a decrease in mobility in a gel retardation assay, and successful transfection is proven by the detection of a reporter gene in cells using fluorescent microscopy. Here, we describe methods to study noncovalent interactions between L5a and plasmid DNA, and the delivery of L5a/DNA complexes into cells. L5a is the one of the smallest CPPs discovered to date, providing a small delivery vehicle for macromolecules in mammalian cells. A small vehicle which can enter the nucleus is ideal for efficient gene uptake, transfer, and therapy. It is simple to complex with DNA plasmids, and its nature allows mammalian cells to be easily transfected.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Klimpel A, Lutzenburg T, Neundorf I (2019) Recent advances of anti-cancer therapies including the use of cell-penetrating peptides. Curr Opin Pharmacol 47:8–13
El-Andaloussi S, Holm T, Langel U (2005) Cell-penetrating peptides: mechanisms and applications. Curr Pharm Des 11:3597–3611
Kalafatovic D, Giralt E (2017) Cell-penetrating peptides: design strategies beyond primary structure and amphipathicity. Molecules 22:E1929
Heitz F, Morris MC, Divita G (2009) Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br J Pharmacol 157:195–206
Green M, Loewenstein PM (1988) Autonomous functional domains of chemically synthesized human immunodeficiency virus Tat trans-activator protein. Cell 55:1179–1188
Frankel AD, Pabo CO (1988) Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 55:1189–1193
Su R, Hu J, Zou Q, Manavalan B, Wei L (2020) Empirical comparison and analysis of web-based cell-penetrating peptide prediction tools. Brief Bioinform 21(2):408–420. https://doi.org/10.1093/bib/bby124
Liu BR, Huang YW, Aronstam RS, Lee HJ (2016) Identification of a short cell-penetrating peptide from bovine lactoferricin for intracellular delivery of DNA in human A549 cells. PLoS One 11:e0150439
Liu BR, Huang YW, Korivi M, Lo SY, Aronstam RS, Lee HJ (2017) The primary mechanism of cellular internalization for a short cell-penetrating peptide as a nano-scale delivery system. Curr Pharm Biotechnol 18:569–584
Lee HJ, Huang YW, Aronstam RS (2019) Intracellular delivery of nanoparticles mediated by lactoferricin cell-penetrating peptides in an endocytic pathway. J Nanosci Nanotechnol 19:613–621
Chang M, Huang YW, Aronstam RS, Lee HJ (2014) Cellular delivery of noncovalently-associated macromolecules by cell-penetrating peptides. Curr Pharm Biotechnol 15:267–275
Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K, Sugiura Y (2001) Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery J Biol Chem 276:5836–5840
Ulasov AV, Rosenkranz AA, Sobolev AS (2018) Transcription factors: time to deliver. J Control Release 269:24–35
Lee HJ, Huang YW, Chiou SH, Aronstam RS (2019) Polyhistidine facilitates direct membrane translocation of cell-penetrating peptides into cells. Sci Rep 9:9398
Neundorf I, Rennert R, Franke J, Kozle I, Bergmann R (2008) Detailed analysis concerning the biodistribution and metabolism of human calcitonin-derived cell-penetrating peptides. Bioconjug Chem 19:1596–1603
Bernkop-Schnürch A (2018) Strategies to overcome the polycation dilemma in drug delivery. Adv Drug Deliv Rev 136–137:62–72
Acknowledgments
This work was supported by the Center for Biomedical Research at Missouri University of Science and Technology, and the Ministry of Science and Technology, Taiwan.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Holl, N.J., Dey, M., Huang, YW., Chiou, SH., Lee, HJ. (2021). Lactoferricin-Derived L5a Cell-Penetrating Peptide for Delivery of DNA into Cells. In: Narayanan, K. (eds) Bio-Carrier Vectors. Methods in Molecular Biology, vol 2211. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0943-9_9
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0943-9_9
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0942-2
Online ISBN: 978-1-0716-0943-9
eBook Packages: Springer Protocols